DE60016198D1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
DE60016198D1
DE60016198D1 DE60016198T DE60016198T DE60016198D1 DE 60016198 D1 DE60016198 D1 DE 60016198D1 DE 60016198 T DE60016198 T DE 60016198T DE 60016198 T DE60016198 T DE 60016198T DE 60016198 D1 DE60016198 D1 DE 60016198D1
Authority
DE
Germany
Prior art keywords
antibacterial
connections
antibacterial connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60016198T
Other languages
English (en)
Other versions
DE60016198T2 (de
Inventor
H Miller
A Newlander
Mark Seefeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Publication of DE60016198D1 publication Critical patent/DE60016198D1/de
Application granted granted Critical
Publication of DE60016198T2 publication Critical patent/DE60016198T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60016198T 1999-06-01 2000-06-01 Antibakterielle verbindungen Expired - Lifetime DE60016198T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13700499P 1999-06-01 1999-06-01
US137004P 1999-06-01
PCT/US2000/015154 WO2000072846A1 (en) 1999-06-01 2000-06-01 Antibacterial compounds

Publications (2)

Publication Number Publication Date
DE60016198D1 true DE60016198D1 (de) 2004-12-30
DE60016198T2 DE60016198T2 (de) 2005-12-01

Family

ID=22475391

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60016198T Expired - Lifetime DE60016198T2 (de) 1999-06-01 2000-06-01 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6573272B1 (de)
EP (1) EP1180030B1 (de)
JP (1) JP4733836B2 (de)
KR (1) KR20020005767A (de)
CN (1) CN1365280A (de)
AR (1) AR024158A1 (de)
AT (1) ATE283049T1 (de)
AU (1) AU773550B2 (de)
BR (1) BR0011121A (de)
CA (1) CA2375630A1 (de)
CO (1) CO5370679A1 (de)
CZ (1) CZ20014290A3 (de)
DE (1) DE60016198T2 (de)
HK (1) HK1045644A1 (de)
HU (1) HUP0201206A3 (de)
IL (1) IL146514A0 (de)
MX (1) MXPA01012326A (de)
NO (1) NO20015722L (de)
NZ (1) NZ515611A (de)
PL (1) PL351959A1 (de)
TR (1) TR200103485T2 (de)
WO (1) WO2000072846A1 (de)
ZA (1) ZA200109733B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
US6730684B1 (en) * 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
DE60029235T2 (de) * 1999-10-08 2007-06-14 Affinium Pharmaceuticals, Inc., Toronto Fab-i-hemmer
US6987115B2 (en) 2000-12-08 2006-01-17 Smithkline Beecham Corporation Antibacterial compounds
CA2432992A1 (en) * 2000-12-21 2002-06-27 Rima Mcleod Fab i and inhibition of apicomplexan parasites
DE60112974T2 (de) * 2001-02-12 2006-02-16 Lilly Icos Llc, Wilmington Carbolinderivate
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
US7790709B2 (en) * 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CA2519429C (en) * 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ATE414082T1 (de) * 2003-04-29 2008-11-15 Oscient Pharmaceuticals Antibiotische tetrahydro-b-carbolinderivative
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) * 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US7854963B2 (en) * 2006-10-13 2010-12-21 Solopower, Inc. Method and apparatus for controlling composition profile of copper indium gallium chalcogenide layers
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
EP2225250A2 (de) 2007-11-30 2010-09-08 Biota Scientific Management Pty Ltd Bicyclische ppat-inhibitoren als antibakterielle mittel
KR101135179B1 (ko) * 2009-02-20 2012-04-16 한국생명공학연구원 ＦａｂＩ 저해 물질 비나산손을 포함하는 항균용 조성물
EP2687531B1 (de) 2011-03-18 2016-07-13 ONO Pharmaceutical Co., Ltd. Tetrahydrocarbolinderivat
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PT3419628T (pt) 2016-02-26 2021-01-05 Debiopharm Int Sa Medicamento para o tratamento de infeções do pé diabético
EP3836919A4 (de) * 2018-08-16 2022-05-18 Recreo Pharmaceuticals Inc. 1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-derivatverbindungen und verwendungen davon

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828068A (en) 1971-05-10 1974-08-06 Tenneco Chem ((substituted indazolyl)-n1-methyl)carbamates
US4154943A (en) 1977-12-29 1979-05-15 University Of Vermont Preparation of vincadifformine
US4267330A (en) * 1978-08-24 1981-05-12 Omnium Chimique Societe Anonyme Process for the synthesis of vincadifformine and related derivatives
FR2619111B1 (fr) * 1987-08-07 1991-01-11 Synthelabo Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5416193A (en) * 1993-04-30 1995-05-16 Pfizer Inc. Coupling reagent and method
MA23420A1 (fr) 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US5614551A (en) 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
JPH10504808A (ja) 1994-06-29 1998-05-12 スミスクライン・ビーチャム・コーポレイション ビトロネクチン受容体拮抗物質
US6451816B1 (en) 1997-06-20 2002-09-17 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
DE19624659A1 (de) 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
JPH10310582A (ja) * 1997-03-13 1998-11-24 Sankyo Co Ltd ピペリジン環縮合カルバペネム化合物
JP2001518094A (ja) 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Ｈｉｖプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US5932743A (en) 1997-08-21 1999-08-03 American Home Products Corporation Methods for the solid phase synthesis of substituted indole compounds
JP4589529B2 (ja) * 1997-12-24 2010-12-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｘａ因子阻害剤としてのインドール誘導体
TR200100631T2 (tr) * 1998-08-20 2002-08-21 Agouron Pharmaceuticals,Inc. Peptit-olmayan GnRH maddeleri
GT199900167A (es) * 1998-10-01 2001-03-21 Nuevos bis-benzimidazoles.
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
AR024077A1 (es) 1999-05-25 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
CO5180605A1 (es) 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
US6346391B1 (en) 1999-07-22 2002-02-12 Trustees Of Tufts College Methods of reducing microbial resistance to drugs
DE60029235T2 (de) 1999-10-08 2007-06-14 Affinium Pharmaceuticals, Inc., Toronto Fab-i-hemmer
JP4961084B2 (ja) 1999-10-08 2012-06-27 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
JP4803935B2 (ja) 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
US6503908B1 (en) 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
US6656703B1 (en) 1999-12-29 2003-12-02 Millennium Pharamaceuticals, Inc. High throughput screen for inhibitors of fatty acid biosynthesis in bacteria
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
EP1332131A2 (de) 2000-11-07 2003-08-06 Bristol-Myers Squibb Company Säurederivate und ihre verwendung als inhibitoren von serinproteasen
US20020107266A1 (en) 2000-12-12 2002-08-08 Marguerita Lim-Wilby Compounds, compositions and methods for treatment of parasitic infections

Also Published As

Publication number Publication date
ATE283049T1 (de) 2004-12-15
AU773550B2 (en) 2004-05-27
ZA200109733B (en) 2002-09-11
NO20015722D0 (no) 2001-11-23
TR200103485T2 (tr) 2002-04-22
IL146514A0 (en) 2002-07-25
AU5177400A (en) 2000-12-18
MXPA01012326A (es) 2002-07-30
EP1180030A1 (de) 2002-02-20
CZ20014290A3 (cs) 2002-05-15
BR0011121A (pt) 2002-02-26
JP4733836B2 (ja) 2011-07-27
EP1180030B1 (de) 2004-11-24
JP2003500448A (ja) 2003-01-07
DE60016198T2 (de) 2005-12-01
NO20015722L (no) 2001-11-23
US20030232850A1 (en) 2003-12-18
US6573272B1 (en) 2003-06-03
AR024158A1 (es) 2002-09-04
EP1180030A4 (de) 2002-09-25
NZ515611A (en) 2004-05-28
PL351959A1 (en) 2003-07-14
WO2000072846A1 (en) 2000-12-07
KR20020005767A (ko) 2002-01-17
CO5370679A1 (es) 2004-02-27
CN1365280A (zh) 2002-08-21
HUP0201206A2 (en) 2002-08-28
CA2375630A1 (en) 2000-12-07
HK1045644A1 (zh) 2002-12-06
US6964970B2 (en) 2005-11-15
HUP0201206A3 (en) 2003-07-28

Similar Documents

Publication Publication Date Title
ATE344248T1 (de) Antibakterielle verbindungen
DE60016198D1 (de) Antibakterielle verbindungen
DE60009915D1 (de) Verbindungen
DE60020763D1 (de) Sterilisationssystem
DE122007000064I1 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
PT1147121E (pt) Antibioticos cetolidos
ATE432265T1 (de) Pyrimidinon verbindungen
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
PT1218009E (pt) Grandulos de quetiapina
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
ATA111299A (de) Schnullersauger
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
PT1218096E (pt) Microcapsulas de libertacao variavel
DE60033075D1 (de) Kodierer
NO20020621D0 (no) Antibakterielle midler
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
PT1235566E (pt) Formulacao injectavel de valnemulina
DE10085008T1 (de) Oberflächenbehandlungsdüse
NO20003024D0 (no) Innkapsling
DE10082008D2 (de) Ausbeulgerät
ATE269311T1 (de) Benzoylpyridazine
ATE440824T1 (de) Nitro-sulfobenzamide